Article | October 6, 2023

Robotic Aseptic Processing

By Austin Roberts, Operations Manager, Sterile Fill-Finish, PCI Pharma Services

Ampoule Aseptic Filling GettyImages-1490244818

Protecting drug products from contamination is a critical step during the manufacture of vaccines and other biologics delivered parenterally. Ensuring particulate and bioburden control, as well as uncompromised sterility, has led to the development of aseptic transfer and containment methods for clinical and commercial sterile injectable products. However, these processes can extend manufacturing timelines and increase costs.

As robotic processing is emerging as a popular method for the primary filling of ready-to-use (RTU) containers, such as vials, syringes and cartridges, robotic aseptic fill ill-finish technology and the use of isolator-barrier systems are key to keeping pace with these requirements.

Robotic processing is expediting the filling process with automation while increasing accuracy, helping to speed life-changing, high-value drug products through the clinical pipeline with efficiency and speed. Examine how robotic technologies are poised to increase manufacturing flexibility and minimize risk as you aim to bring your biologic to market.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader